š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This was a 24-month, open-label extension study that followed an 8-week dou...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00891293
Treatments Being Tested
The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Status
Completed
Location
Amarin Investigational Site
Start Date
2009-12
Trial ID
NCT01047501
Treatments Being Tested
The purpose of this study is to better understand the anti-inflammatory ben...
Status
Completed
Location
Clinical and Translational Research Center (CTRC); Hospital of the University of Pennsylvania
Start Date
2010-01
Trial ID
NCT01048502
Treatments Being Tested
AMR101 (icosapent ethyl \[ethyl-EPA\]) is a highly purified ethyl ester of ...
Status
Completed
Location
Amarin Investigational Site
Start Date
2011-11
Trial ID
NCT01492361
Treatments Being Tested
This study is to determine a dose response signal for LCQ908 monotherapy an...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01594983
Treatments Being Tested
The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Status
Completed
Location
Amarin Investigational Site
Start Date
2009-12
Trial ID
NCT01047683
Treatments Being Tested
The purpose of OM5/LOV111859 was to evaluate efficacy and safety of Omacor ...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00246636
Treatments Being Tested